221 related articles for article (PubMed ID: 23834144)
1. Functional role of miR-34 family in human cancer.
Wang R; Ma J; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
Curr Drug Targets; 2013 Sep; 14(10):1185-91. PubMed ID: 23834144
[TBL] [Abstract][Full Text] [Related]
2. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy.
Alizadeh M; Safarzadeh A; Beyranvand F; Ahmadpour F; Hajiasgharzadeh K; Baghbanzadeh A; Baradaran B
J Cell Physiol; 2019 Nov; 234(11):19280-19297. PubMed ID: 30950056
[TBL] [Abstract][Full Text] [Related]
3. Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.
Li C; Gao Y; Zhang K; Chen J; Han S; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 37(6):2143-59. PubMed ID: 26606597
[TBL] [Abstract][Full Text] [Related]
4. Insights into the diverse roles of miR-205 in human cancers.
Orang AV; Safaralizadeh R; Hosseinpour Feizi MA
Asian Pac J Cancer Prev; 2014; 15(2):577-83. PubMed ID: 24568460
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential.
Khordadmehr M; Jigari-Asl F; Ezzati H; Shahbazi R; Sadreddini S; Safaei S; Baradaran B
J Cell Physiol; 2019 Dec; 234(12):21716-21731. PubMed ID: 31140618
[TBL] [Abstract][Full Text] [Related]
8. Application of the microRNA-302/367 cluster in cancer therapy.
Liu J; Wang Y; Ji P; Jin X
Cancer Sci; 2020 Apr; 111(4):1065-1075. PubMed ID: 31957939
[TBL] [Abstract][Full Text] [Related]
9. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21: a novel therapeutic target in human cancer.
Pan X; Wang ZX; Wang R
Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
[TBL] [Abstract][Full Text] [Related]
11. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
Liu B; Li J; Zheng M; Ge J; Li J; Yu P
Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
[TBL] [Abstract][Full Text] [Related]
12. Diverse functions of miR-373 in cancer.
Wei F; Cao C; Xu X; Wang J
J Transl Med; 2015 May; 13():162. PubMed ID: 25990556
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
Zhang T; Zou P; Wang T; Xiang J; Cheng J; Chen D; Zhou J
Tumour Biol; 2016 Jul; 37(7):8931-40. PubMed ID: 26753959
[TBL] [Abstract][Full Text] [Related]
14. miR-655: A promising regulator with therapeutic potential.
Li H; Zhang J; Yang Y; Duan S
Gene; 2020 Oct; 757():144932. PubMed ID: 32640310
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-224: as a potential target for miR-based therapy of cancer.
Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
[TBL] [Abstract][Full Text] [Related]
16. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
Bayraktar R; Van Roosbroeck K
Cancer Metastasis Rev; 2018 Mar; 37(1):33-44. PubMed ID: 29282605
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of miR-638 in the progression of cancers.
Chong ZX; Yeap SK; Ho WY
Pathol Res Pract; 2021 Apr; 220():153351. PubMed ID: 33642053
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
19. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
20. MiR-138: A promising therapeutic target for cancer.
Sha HH; Wang DD; Chen D; Liu SW; Wang Z; Yan DL; Dong SC; Feng JF
Tumour Biol; 2017 Apr; 39(4):1010428317697575. PubMed ID: 28378633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
